IPO
December 17, 2010 source: GreenTech Solar Nat’s post “2011 Is the Year of the IPO” was featured on GreenTech Solar Enphase, MiaSolé and BrightSource could all go public in a rebounding economy focused on green, contends Claremont Creek’s Nat Goldhaber. Given the enormous brouhaha that has surrounded clean technology for several years, the wait for […]
Read MoreDecember 10, 2010 source: VentureBeat What to watch for in cleantech in 2011: companies, IPOs and trends Tis the season for next-year forecasts, so VentureBeat asked a few cleantech venture capitalists for their thoughts on clean energy trends to watch in 2011. Nat Goldhaber of Claremont Creek Ventures tells us that next year is The […]
Read MoreI spoke to Venture Capital Journal’s reporter Mark Boslet about the Cleantech market recently. My thoughts appeared in the November issue of the publication. Here is an excerpt of what we discussed. It has been a long time coming, but 2011 is looking like a pivotal year for cleantech IPOs. Suddenly the IPO market for […]
Read MoreJamie Montgomery with Nat Goldhaber On Wednesday September 15, my partners and I joined 22 of our portfolio companies and the Claremont Creek hosted speaker– investment bankers Jamie Montgomery, Eric Wagner, and Jason Yip– for our second Turbo Talks event this year. Turbo Talks refers to the gathering we created for our portfolio where we […]
Read MoreThe classical view of venture capital is that a VC invests in a company, grows it into revenue and breakeven, and then sells equity in it to the public in an IPO. The exit part is the VC’s can then sell their ownership interest in the startup to that public market of buyers as the company grows in value, or distribute their now-liquid shares to their limited partner investors to sell
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.